Singapore’s Biomedicine Initiative: Prescription for Growth?

The paper highlights meetings and interviews with government, research and development, and business executives that took place in Singapore in December 2001. The paper discuss the goals, strategy and programs of Singapore’s economic development “model” as applied to its biomedical initiative to describe the current biomedical sector, and to evaluate short and long-term implications for America’s biomedical industry.